Federal Register / Vol. 69, No. 237 / Friday, December 10, 2004 / Notices 71851

DEPARTMENT OF JUSTICE

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of the National Cooperation 

Research and Production Act of 

1993—National Committee for Clinical 

Laboratory Standards 

Notice is hereby given that, on 

September 16, 2004, pursuant to section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), 

National Committee for Clinical 

Laboratory Standards (‘‘NCCLS’’) has 

filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing (1) the name and 

principal place of business of the 

standards development organization 

and (2) the nature and scope of its 

standards development activities. The 

notifications were filed for the purpose 

of invoking the Act’s provisions limiting 

the recovery of antitrust plaintiffs to 

actual damages under specified 

circumstances. 

Pursuant to section 6(b) of the Act, the 

name and principal place of business of 

the standards development organization 

is: National Committee for Clinical 

Laboratory Standards, Wayne, PA. (On 

January 1, 2005 the organization’s name 

will become: Clinical and Laboratory 

Standards Institute). The nature and 

scope of NCCLS’s standards 

development activities are: to improve 

the quality of work performed by 

organizations concerned with health 

care services, medical testing, and 

clinical and other laboratory services. 

Examples include training verification; 

safety of healthcare workers; preanalytic 

specimen collection and handling; 

evaluation of analytical methods and 

devices; analytic procedures in clinical 

chemistry and toxicology, hematology, 

immunology and ligand assay, 

microbiology, and molecular methods; 

performance goals for internal quality 

control; point of service testing in acute 

and chronic care facilities; physician’s 

office laboratory testing; cytologic 

specimen collection and cytoprepatory 

techniques; laboratory design; 

laboratory automation and informatics; 

and emergency response procedures.

Dorothy B. Fountain, 

Deputy Director of Operations, Antitrust 

Division.

[FR Doc. 04–27068 Filed 12–9–04; 8:45 am] 

BILLING CODE 4410–11–M

DEPARTMENT OF JUSTICE

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—North American Security 

Products Organization 

Notice is hereby given that, on 

November 18, 2004, pursuant to section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), North 

American Security Products 

Organization (‘‘NASPO’’) has filed 

written notifications simultaneously 

with the Attorney General and the 

Federal Trade Commission disclosing 

(1) the name and principal place of 

business of the standards development 

organization and (2) the nature and 

scope of its standards development 

activities. The notifications were filed 

for the purpose of invoking the Act’s 

provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Pursuant to section 6(b) of the Act, the 

name and principal place of business of 

the standards development organization 

is: North American Security Products 

Organization, Washington, DC. The 

nature and scope of NASPO’s standards 

development activities are: to certify 

that providers of security documents, 

lables, cards, packaging, materials and 

technology, operate under an agreedupon set of operational standards and 

security protocols.

Dorothy B. Fountain, 

Deputy Director of Operations, Antitrust 

Division.

[FR Doc. 04–27069 Filed 12–9–04; 8:45 am] 

BILLING CODE 4410–11–M

DEPARTMENT OF JUSTICE

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—RapidIO Trade 

Association 

Notice is hereby given that, on 

September 22, 2004, pursuant to section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), 

RapidIO Trade Association (‘‘RapidIO’’) 

had filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing (1) the name and 

principal place of business of the 

standards development organization 

and (2) the nature and scope of its 

standards development activities. The 

notifications were filed for the purpose 

of invoking the Act’s provisions limiting 

the recovery of antitrust plaintiffs to 

actual damages under specified 

circumstances. 

Pursuant to section 6(b) of the Act, the 

name and principal place of business of 

the standards development organization 

is: RapidIO Trade Association, Austin, 

TX. The nature and scope of RapidIO’s 

standards development activities are: To 

direct the future development and drive 

the adoption of the RapidIO 

architecture. The RapidIO Interconnect 

Architecture, designed to be compatible 

with the most popular integrated 

communications processors, host 

processors, and networking digital 

signal processors, is a high-performance, 

packet-switched, interconnect 

technology.

Dorothy B. Fountain, 

Deputy Director of Operations, Antitrust 

Division.

[FR Doc. 04–27060 Filed 12–9–04; 8:45 am] 

BILLING CODE 4410–11–M

DEPARTMENT OF JUSTICE

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Wisconsin Certification 

Board, Inc. 

Notice is hereby given that, on 

September 27, 2004, pursuant to section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), 

Wisconsin Certification Board, Inc. 

(‘‘WCB’’) has filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing (1) the name and 

principal place of business of the 

standards development organization 

and (2) the nature and scope of its 

standards development activities. The 

notifications were filed for the purpose 

of invoking the Act’s provisions limiting 

the recovery of antitrust plaintiffs to 

actual damages under specified 

circumstances. 

Pursuant to section 6(b) of the Act, the 

name and principal place of business of 

the standards development organization 

is: Wisconsin Certification Board, Inc., 

Wauwatosa, WI. The nature and scope 

of WCB’s standards development 

activities are: To promote the quality 

and accessibility of substance use 

disorder counseling, clinical 

supervision services, and prevention 

services to the citizens of Wisconsin 

through: (1) Certifications for substance 

use disorder counselors; clinical